196 related articles for article (PubMed ID: 28088330)
21. The roles of pathology in targeted therapy of women with gynecologic cancers.
Murali R; Grisham RN; Soslow RA
Gynecol Oncol; 2018 Jan; 148(1):213-221. PubMed ID: 29174566
[TBL] [Abstract][Full Text] [Related]
22. Next-Generation Sequencing: Role in Gynecologic Cancers.
Evans T; Matulonis U
J Natl Compr Canc Netw; 2016 Sep; 14(9):1165-73. PubMed ID: 27587626
[TBL] [Abstract][Full Text] [Related]
23. Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy.
Lu B; Jiang R; Xie B; Wu W; Zhao Y
Cell Death Dis; 2021 Aug; 12(8):783. PubMed ID: 34381020
[TBL] [Abstract][Full Text] [Related]
24. [Abnormalities of DNA repair and gynecological cancers].
Auguste A; Leary A
Bull Cancer; 2017 Nov; 104(11):971-980. PubMed ID: 29054544
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
Basu P; Mukhopadhyay A; Konishi I
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():131-136. PubMed ID: 30306576
[TBL] [Abstract][Full Text] [Related]
27. Asian Society of Gynecologic Oncology International Workshop 2018.
Kong TW; Ryu HS; Kim SC; Enomoto T; Li J; Kim KH; Shim SH; Wang PH; Therasakvichya S; Kobayashi Y; Lee M; Shi T; Lee SW; Mikami M; Nagase S; Lim MC; Wang J; Wilailak S; Kim SW; Hong SH; Tan DS; Mandai M; Chang SJ; Huang RYJ; Ushijima K; Lee JY; Chen X; Ochiai K; Lee TS; Yang B; Kalam F; Lv Q; Ahmad MF; Yaznil MR; Modi KB; Manopunya M; Jeong DH; Lertkhachonsuk AA; Chung HH; Watari H; Jeon S
J Gynecol Oncol; 2019 Mar; 30(2):e39. PubMed ID: 30740961
[TBL] [Abstract][Full Text] [Related]
28. Major clinical research advances in gynecologic cancer in 2014.
Suh DH; Lee KH; Kim K; Kang S; Kim JW
J Gynecol Oncol; 2015 Apr; 26(2):156-67. PubMed ID: 25872896
[TBL] [Abstract][Full Text] [Related]
29. Initiation of a formalized precision medicine program in gynecologic oncology.
Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
[TBL] [Abstract][Full Text] [Related]
30. Metastatic gynecologic malignancies: advances in treatment and management.
Chan JK; Chow S; Bhowmik S; Mann A; Kapp DS; Coleman RL
Clin Exp Metastasis; 2018 Aug; 35(5-6):521-533. PubMed ID: 29931499
[TBL] [Abstract][Full Text] [Related]
31. Update on Genetic Testing in Gynecologic Cancer.
Domchek SM; Robson ME
J Clin Oncol; 2019 Sep; 37(27):2501-2509. PubMed ID: 31403865
[No Abstract] [Full Text] [Related]
32. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
33. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
34. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
35. Telomerase in gynecologic cancers.
Eltabbakh GH
Obstet Gynecol; 1997 Dec; 90(6):1015-9. PubMed ID: 9397123
[TBL] [Abstract][Full Text] [Related]
36. [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved].
Ray-Coquard I; Chauvin F; Leblanc E; Caux C; Hoarau H; Bonnetain F; Christophe V; Sastre-Garau X; Lazennec G; Poulain L; Haie-Meder C; Pujade-Lauraine E; Salzet M; Deutsch E; Devouassoux M; Penault Llorca F; Lecuru F; Taieb S; Arveux P; Theillet C; Joly F
Bull Cancer; 2012 Apr; 99(4):479-98. PubMed ID: 22469552
[TBL] [Abstract][Full Text] [Related]
37. Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.
Jou J; Kato S; Miyashita H; Thangathurai K; Pabla S; DePietro P; Nesline MK; Conroy JM; Rubin E; Eskander RN; Kurzrock R
Mol Cancer Ther; 2023 Nov; 22(11):1352-1362. PubMed ID: 37619986
[TBL] [Abstract][Full Text] [Related]
38. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
39. Is the NCI MATCH trial a match for gynecologic oncology?
Moore KN; Mannel RS
Gynecol Oncol; 2016 Jan; 140(1):161-6. PubMed ID: 26586415
[TBL] [Abstract][Full Text] [Related]
40. Race-associated molecular changes in gynecologic malignancies.
Asare A; Yao H; Lara OD; Wang Y; Zhang L; Sood AK
Cancer Res Commun; 2022 Feb; 2(2):99-109. PubMed ID: 35992327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
